Clinical Trial Details
— Status: Recruiting
Administrative data
| NCT number |
NCT00166946 |
| Other study ID # |
9361701179 |
| Secondary ID |
|
| Status |
Recruiting |
| Phase |
N/A
|
| First received |
September 12, 2005 |
| Last updated |
December 20, 2005 |
| Start date |
June 2005 |
| Est. completion date |
January 2008 |
Study information
| Verified date |
November 2004 |
| Source |
National Taiwan University Hospital |
| Contact |
Hsin-Su Yu, MD PHD |
| Phone |
886-2-23562141 |
| Email |
dermyu[@]ha.mc.ntu.edu.tw |
| Is FDA regulated |
No |
| Health authority |
Taiwan: Department of Health |
| Study type |
Interventional
|
Clinical Trial Summary
We popose that arsenic-induced lymphocytes dysfunction plays an important role in biological
mechanisms of arsenical Bowen’s disease.
Description:
Arsenical cancers (comprising skin, bladder, kidney, lung, colon and liver malignancies)
were prevalent in southwestern coast of Taiwan where the artesian water was contaminated
with high concentration of arsenic. Skin is a main target of arsenical poisoning. The
cutaneous manifestations of chronic arsenism can take form as hyperpigmentation,
hypopigmentation, arsenical keratosis and arsenical skin cancers. The most popular arsenical
skin cancer is Bowen’s disease, which is a carcinoma in situ of skin and often confined to
sun-protected skin. Pathologically, there are several characteristics present in Bowen’s
disease: (1) abnormal cell proliferation and carcinogenesis in keratinocytes; (2) dysplasia
and apoptosis at the lesion; (3) integrin deficiency/defect in the basal cells of the skin;
(4) dysfunctions in peripheral immune cells. Our pervious results indicated that arsenic
affected cell cycle regulation by influencing the proliferation and apoptosis of
keratinocytes. Furthermore, we found that integrins were deficient in basal layer of
lesional and perilesional sites of Bowen’s disease as demonstrated by immunohistochemistry.
The integrin deficiency in Bowen’s disease might lead to abnormality of cell cycle
regulation, differentiation and carcinogenesis. In addition, arsenic can destruct
lymphocytes to cytokine regulation and induce lymphocytes apoptosis. We propose that
arsenic-induced lymphocytes dysfunction plays an important role in biological mechanisms of
arsenical Bowen’s disease. There are many regulatory mechanisms involved in progression of
chemical carcinogenesis, including the reactions among carcinogen and target cells,
supporting cells and immune interactions. Therefore, this study is to investigate these skin
cell-cell interactions induced by arsenic using an organotypic epidermis culture model. By
using this model, we can mimic the mechanism of arsenic-induced skin diseases. Which will
give us much more information that similar to carcinogenesis progesee in human body as
compared to cell culture model. The effects of arsenic on epidermis formation, the effects
of UVB and arsenic on arsenical carcinogenesis and the interactions between immune cells and
skin cells will be studied in this 3-year proposal as described below:
The 1st year: Study of arsenical effects on integrin expression, cell proliferation,
differentiation and apoptosis in organotypic epidermis.
The 2nd year: Study of arsenic and/or UVB –induced biological changes in organotypic
epidermis and Bowen’s disease.
The 3rd year: Study of the interactions between immune cells and epidermal cells induced by
arsenic.
This study will give us much more information that similar to carcinogenesis progesee in
human body as compaired to cell culture model. We hope the result of this study can provide
a useful model in chemical carcinogenesis investigation field.
